Assignee
MEDIPURE PHARMACEUTICALS INC
CA·1 granted patent·3 pending applications·1 citations·filing 2019–2022
Top patents by PatentIndex Score
4 records- 0162US11147805B2Cannabinoid receptor agonists and serine hydrolase enzyme inhibitor based anxiolytic therapeutic productMEDIPURE PHARMACEUTICALS INC·Filed 2019·Granted Oct 19, 2021·1 cites·21 claims
- 0243US2020253948A1Cannabinoid receptor agonists and serine hydrolase enzyme inhibitor based anxiolytic therapeutic productMEDIPURE PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0340US2022339150A1Endocannabinoid system-targeting prodrugs and therapeutic uses thereofMEDIPURE PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0440US2022378744A1Compounds for treating proliferator-activated receptors (ppar) mediated diseases or conditionsMEDIPURE PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MEDIPURE PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →